Suppr超能文献

一种使用稳定同位素标记的黄嘌呤和液相色谱/串联质谱法对人血浆黄嘌呤氧化还原酶活性进行的高灵敏度检测。

A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC/TQMS.

作者信息

Murase Takayo, Nampei Mai, Oka Mitsuru, Miyachi Atsushi, Nakamura Takashi

机构信息

Mie Research Laboratories, Sanwa Kagaku Kenkyusho Co., Ltd., Inabe-shi, Mie 511-0406, Japan.

Mie Research Laboratories, Sanwa Kagaku Kenkyusho Co., Ltd., Inabe-shi, Mie 511-0406, Japan.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Dec 15;1039:51-58. doi: 10.1016/j.jchromb.2016.10.033. Epub 2016 Oct 24.

Abstract

Associations between elevated plasma xanthine oxidoreductase (XOR) activity and various pathologies have been widely reported. However, it has been difficult to accurately measure human plasma XOR activity because the XOR activity of humans is lower than that of animals such as mouse. We developed a highly sensitive assay for XOR activity utilizing a combination of [C,N] xanthine and liquid chromatography/triple quadrupole mass spectrometry. In the present study, we established and validated a novel human plasma XOR activity assay utilizing this technique. The calibration curve of [C,N]uric acid showed linearity over the range of 4-4000nM (r>0.995) with a lower limit of quantitation of 4nM which corresponds to an XOR activity of 6.67pmol/h/mL plasma. Intra- and inter-assay coefficients of variation of pooled human plasma XOR activity were 6.5% and 9.1%, respectively. Plasma XOR activities of 20 healthy volunteers ranged from 32.8 to 227pmol/h/mL (mean±SD=89.1±55.1, n=20), which correlated with alanine transaminase (r=0.827), aspartate transaminase (r=0.487), and uric acid (r=0.502). The established assay is expected to be useful for investigating the function of XOR and the effect of its inhibitors in various diseases.

摘要

血浆黄嘌呤氧化还原酶(XOR)活性升高与各种病理状况之间的关联已被广泛报道。然而,由于人类的XOR活性低于小鼠等动物,因此很难准确测量人类血浆中的XOR活性。我们开发了一种利用[C,N]黄嘌呤与液相色谱/三重四极杆质谱联用的高灵敏度XOR活性检测方法。在本研究中,我们建立并验证了一种利用该技术的新型人类血浆XOR活性检测方法。[C,N]尿酸的校准曲线在4 - 4000nM范围内呈线性(r>0.995),定量下限为4nM,对应XOR活性为6.67pmol/h/mL血浆。合并的人类血浆XOR活性的批内和批间变异系数分别为6.5%和9.1%。20名健康志愿者的血浆XOR活性范围为32.8至227pmol/h/mL(平均值±标准差=89.1±55.1,n = 20),与丙氨酸转氨酶(r = 0.827)、天冬氨酸转氨酶(r = 0.487)和尿酸(r = 0.502)相关。预期所建立的检测方法将有助于研究XOR的功能及其抑制剂在各种疾病中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验